Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018681 (
headache
)
56,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The clinical utility of Tellegen's Absorption Scale was examined using a sample of 32 chronic
vascular headache
patients drawn from a larger treatment study investigating the efficacy of thermal biofeedback with
vascular headache
. A regression analysis found that acquisition of the hand-warming response was directly related to increase in capacity for absorption. Conversely, a trend was found for absorption capacity to be inversely related to reductions in
headache
frequency and intensity. Reasons for these differences in process and outcome variables are discussed.
...
PMID:The role of absorption capacity in thermal biofeedback treatment of vascular headache. 193 64
The records of 21 patients admitted to hospital from January 1985 to December 1988 for acute
headache
associated with cocaine intoxication were reviewed. Fifteen patients were identified who experienced
headaches
with migrainous features in the absence of neurological or systemic complications. None of them had a history of cocaine-unrelated
headaches
or a family history of migraine, and all had a favourable outcome. Three possible mechanisms of cocaine-related
vascular headaches
are discussed which depend on the interval between cocaine ingestion and development of the
headache
. We postulate that acute
headaches
following cocaine use may relate to the sympathomimetic or vasoconstrictive effects of cocaine, while
headaches
following cocaine withdrawal or exacerbated during a cocaine "binge" may relate to cocaine-induced alteration of the serotoninergic system.
...
PMID:Cocaine-related vascular headaches. 195 99
Stroke rarely occurs in a young patient with migraine. Nevertheless,
vascular headache
can lead to catastrophic neurologic consequences, and severe
headache
associated with persistent neurologic deficits poses a complex diagnostic problem.
...
PMID:When migraine is more than a headache. Stroke in a young patient. 203 Oct 34
Two cases of
headache
during pregnancy were associated with MRI findings suggestive of venous sinus thrombosis. The findings, however, were atypical, and of uncertain clinical significance. Venous sinus thrombosis typically does not occur during the first and second trimesters (less than 10 percent of reported cases). Thus, these two cases are doubly unusual. The correct significance of these equivocal MRI findings of possible venous sinus thrombosis must be understood so that unnecessary and potentially harmful therapies are not employed, and so that appropriate management of what may otherwise be a typical
vascular headache
syndrome may be undertaken.
Headache
1991 Apr
PMID:Atypical MRI findings of venous sinus thrombosis in pregnancy: clinical significance relating to episodic vascular headache. 205 May 19
This article reports on a study concerning the relationship between migraine headaches and the use of the low-dose oral contraceptives Rigevidon and Anteovin. The objective was to examine how hormonal contraception influences
vascular headaches
and to what extent does it provoke such complaints. The study involved 138 and 441 women taking Rigevidon and Anteovin, respectively, 7.9-10.1% of whom already suffered from migraine headaches before taking the pill. Researchers observed the time of the development of the migrainous attack, its duration and intensity, and its course during each cycle. In the event of very intense
headaches
, the researchers changed the oral contraceptive to Ovidon or Continuin, or discontinued treatment (treatment was also discontinued in cases of increases in blood pressure). Of the women already suffering from
headaches
prior to taking the oral contraceptives, most of them suffered from a typical menstrual migraines caused by premenstrual syndrome which lasted for 2-4 days. The study found that the women on Rigevidon were less likely to suffer from
vascular headaches
than the women on Anteovin. While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon. Researchers attribute these differences to the fact that Anteovin has a higher oestrogen content than Rigevidon. While the study does not explain the correlation between low-dose oral contraceptives and
vascular headaches
, it does point out the risk associated with oestrogen.
...
PMID:The relationship between vascular headaches and low-dose oral contraceptives. 209 59
The author reviews the diagnosis of various
vascular headaches
, with an emphasis on migraine, and explains their pharmacological and non pharmacological treatments. In addition, difficult areas such as 'status migranosus', complicated migraine and migraine in pregnancy are discussed. Finally, some unusual
headache
variants are presented.
...
PMID:Migraine and other vascular headaches. An overview of diagnosis and management. 182 29
It is well established that multiple influences regulate cerebral blood flow; the overwhelming evidence continues to suggest that migraine is a disorder, albeit temporary, of cerebral hemodynamics. Thus, the classical theory of migraine is no longer tenable as viewed strictly and rigidly. Perhaps it would be easier to say that the migraine's aura is characterized by reduction in blood flow, often hemispheric, and that sometime during the
headache
phase cerebral hyperperfusion occurs. The process is under the control of multiple factors: neurogenic, chemical, metabolic, and myogenic. The blood flow changes do not necessarily correlate with the patient's symptoms. Thus, even now, migraine and other
vascular headaches
remain as descriptive diagnoses. The final pathology of migraine remains to be determined.
...
PMID:The pathology of migraine. 213 18
One-hundred-sixteen patients suffering from
vascular headache
(migraine or combined migraine and tension) were, after 4 weeks of pretreatment baseline
headache
monitoring, randomly assigned to one of four conditions: (a) thermal biofeedback with adjunctive relaxation training (TBF); (b) TBF plus cognitive therapy; (c) pseudomediation as an ostensible attention-placebo control; or (d)
headache
monitoring. The first three groups received 16 individual sessions over 8 weeks, while the fourth group continued to monitor
headaches
. All groups then monitored
headaches
for a 4-week posttreatment baseline. Analyses revealed that all treated groups improved significantly more than the
headache
monitoring group with no significant differences among the three treated groups. On a measure of clinically significant improvement, the two TBF groups had slightly higher (51%) degree of improvement than the meditation group (37.5%). It is argued that the attention-placebo control became an active relaxation condition.
...
PMID:A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. 218 67
Migraine (vascular)
headache
is a complex syndrome that involves vascular hyperreactivity. The functions of systemic mediators in migraine are not fully understood. It is unclear which mediators provoke this probably atopic disorder and which represent an attempt to correct an imbalance. However, it has been demonstrated fairly conclusively that increased histamine levels correlate with migraine attacks in susceptible persons. Recent studies showing that histamine seems to have many different receptors and to adopt different conformations for different receptors may serve as a useful guide to future scientific investigation. Further impetus may come from ongoing studies of H3 histamine receptors, which indicate that H3 agonists offer promise as prophylactic agents for people who suffer from
vascular headaches
.
...
PMID:The role of antihistamine therapy in vascular headaches. 222 34
Whether multiple sclerosis (MS) can cause
headaches
is controversial. To clarify the association between
headaches
and MS we prospectively analyzed 104 consecutive MS patients using detailed
headache
evaluations. Fifty-four patients (52%) reported
headaches
, compared with 5 of 35 (14%) patients initially suspected to have MS but subsequently proven to have other disorders, and 18 of 100 (18%) matched general neurology patients. The MS patients had tension headaches or
vascular headaches
of the migraine type; there was no distinctive "MS
headache
." Seven of these patients had
headaches
with their first MS symptoms, but in only one did
headaches
recur with disease activity.
Headaches
did not correlate with any clinical features of MS. We conclude that an association between
headaches
and MS may exist.
...
PMID:Headaches and multiple sclerosis: a clinical study and review of the literature. 223 Aug 44
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>